gadolinium dtpa has been researched along with gallium ga 68 dotatate in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (gallium ga 68 dotatate) | Trials (gallium ga 68 dotatate) | Recent Studies (post-2010) (gallium ga 68 dotatate) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 403 | 14 | 372 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armbruster, M; Auernhammer, CJ; Ceelen, F; Haug, A; Reiser, MF; Rist, C; Singnurkar, A; Sommer, WH; Sourbron, S; Zech, CJ | 1 |
1 other study(ies) available for gadolinium dtpa and gallium ga 68 dotatate
| Article | Year |
|---|---|
Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |